Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer.

Item

http://www.wikidata.org/entity/Q55315506

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Effect of combination therapy ...... astasis of human colon cancer.

@en

Effect of combination therapy ...... astasis of human colon cancer.

@nl

type

Item

label

Effect of combination therapy ...... astasis of human colon cancer.

@en

Effect of combination therapy ...... astasis of human colon cancer.

@nl

prefLabel

Effect of combination therapy ...... astasis of human colon cancer.

@en

Effect of combination therapy ...... astasis of human colon cancer.

@nl

P1476

Effect of combination therapy ...... astasis of human colon cancer.

@en

P2093

A Igarashi

http://www.w3.org/2001/XMLSchema#string

H Konno

http://www.w3.org/2001/XMLSchema#string

K Kamiya

http://www.w3.org/2001/XMLSchema#string

K Oba

http://www.w3.org/2001/XMLSchema#string

M Baba

http://www.w3.org/2001/XMLSchema#string

M Ohta

http://www.w3.org/2001/XMLSchema#string

S Nakamura

http://www.w3.org/2001/XMLSchema#string

T Kaneko

http://www.w3.org/2001/XMLSchema#string

T Syouji

http://www.w3.org/2001/XMLSchema#string

T Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen

Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies.

Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA

Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.

Preventive effect of matrix metalloproteinase inhibitor, R-94138, in combination with mitomycin C or cisplatin on peritoneal dissemination of human gastric cancer cell line TMK-1 in nude mice.

The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application.

P304

688-695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2001.TB01149.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229728322

http://www.w3.org/2001/XMLSchema#string

P698

11429059

http://www.w3.org/2001/XMLSchema#string

P932

5926761

http://www.w3.org/2001/XMLSchema#string